This year’s PharmedOut conference will focus on how patient harms may result from industry promotion.
Speakers include:
- Shannon Brownlee, New America Foundation
- Rita Redberg, M.D., Editor-in-chief, Archives of Internal Med
- Carl Elliott, M.D., Ph.D., Author, White Coat, Black Hat
- Kay Dickersin, Ph.D., Johns Hopkins University
- Susan Wood, Ph.D., George Washington University
- Sean Flynn, J.D., American University
- Joel Lexchin, M.D., York University
- Barbara Mintzes, Therapeutics Initiative
Topics include:
- Innovative Drugs: Hard Facts and Tribal Myths
- Does Direct-To-Consumer Advertising Educate the Public to Misuse Medicines?
- Underuse of Classic Drugs
- Antipsychotic Use in Children
- Can Clinical Trial Data be Hidden?
- Radiation From Medical Imaging: A Hidden Epidemic
- Regulating Medical Devices: A Historical Perspective
- Cardiovascular Devices: The Role of Evidence in the FDA Approval Process
- The Failure of the DePuy ASR Hip Prosthesis: Implications for Medical Device Initiatives
- Left To Our Own Devices: A Surgeon’s Perspective
- Doctors and Devices
- Should device reps be in the OR?
- What Can and Should the States Do?
- The Supreme Court Strikes Back: IMS v. Sorrell – a Constitutional Right to Track Prescription Data?
- Disclosure of Physician Industry Relationships: Data from Washington, D.C.
- Testing the Limits of FDA Authority
- Federal enforcement
- Congressional oversight
- Penicillin and Panaceas
- Exploiting Homeless Mentally Ill Patients in Drug Safety Trials
- Promoting Prudent Prescribing: A Culture of Resource Stewardship
- Role of the Media